Skip to content
bio concept art

Tag: cell and gene therapy

News

SK pharmteco Unites Leading Brands to Create Global Powerhouse in CDMO Services

FOR IMMEDIATE RELEASE Streamlined Organization Lays Foundation for Company Rebrand RANCHO CORDOVA, CA (December 11, 2024) — SK pharmteco, a...

White Paper

Ensure Safety with Robust Replication-Competent Lentivirus (RCL) Assay: New White Paper

The safe application of lentiviral vectors in cell and gene therapy depends on precise risk mitigation strategies, particularly concerning replication-competent...

Webinar

Viral vector integrity analysis – Advancements in gene therapy development 

Gene therapy offers significant potential for addressing various genetic disorders. Over 30 gene therapies have received FDA approval, with more...

Press Release

SK pharmteco Unites Leading Brands to Create Global Powerhouse in CDMO Services

FOR IMMEDIATE RELEASE RANCHO CORDOVA, CA (December 11, 2024) — SK pharmteco, a global contract development, manufacturing, and analytical testing...

Webinar

Advancing Viral Vector Manufacturing with Innovation: The Importance of the Cell Line

Join our experts for this on-demand 30-minute webinar to discuss the importance of cell lines in viral vector manufacturing, a...

Brochure

Cell and Gene CDMO Services

SK pharmteco provides specialized solutions for Cell and Gene Therapy, encompassing viral vector manufacturing, plasmid DNA production, analytical testing, and...

White Paper

Adapting a rcAAV Assay for Commercial Manufacturing

This white paper from SK pharmteco explores the development of a robust, GMP-compliant assay for detecting replication competent Adeno-Associated Virus...

Brochure

Stability and Storage Testing

SK pharmteco offers comprehensive storage and stability testing services to support the quality and compliance of pharmaceutical products. With ICH-compliant...

News

SK pharmteco and AaviGen Announce Strategic Partnership to Manufacture AaviGen’s Lead Gene Therapy Product for Heart Failure

FOR IMMEDIATE RELEASE  PARIS, France and HEIDELBERG, Germany (October 2, 2024) – SK pharmteco, a global contract development and manufacturing...